A citation-based method for searching scientific literature

C S Lee, A Samii, V Sossi, T J Ruth, M Schulzer, J E Holden, J Wudel, P K Pal, R de la Fuente-Fernandez, D B Calne, A J Stoessl. Ann Neurol 2000
Times Cited: 366







List of co-cited articles
1209 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
Jeffrey H Kordower, C Warren Olanow, Hemraj B Dodiya, Yaping Chu, Thomas G Beach, Charles H Adler, Glenda M Halliday, Raymond T Bartus. Brain 2013
547
22

PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.
John R Adams, Hinke van Netten, Michael Schulzer, Edwin Mak, Jessamyn Mckenzie, Audrey Strongosky, Vesna Sossi, Thomas J Ruth, Chong S Lee, Matthew Farrer,[...]. Brain 2005
185
20

Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease.
Ramachandiran Nandhagopal, Lisa Kuramoto, Michael Schulzer, Edwin Mak, Jacqueline Cragg, Jess McKenzie, Siobhan McCormick, Thomas J Ruth, Vesna Sossi, Raul de la Fuente-Fernandez,[...]. Brain 2011
86
20

Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake.
H T Benamer, J Patterson, D J Wyper, D M Hadley, G J Macphee, D G Grosset. Mov Disord 2000
237
16


Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.
R Nandhagopal, L Kuramoto, M Schulzer, E Mak, J Cragg, Chong S Lee, J McKenzie, S McCormick, A Samii, A Troiano,[...]. Brain 2009
149
16

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
A J Hughes, S E Daniel, L Kilford, A J Lees. J Neurol Neurosurg Psychiatry 1992
15

Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
Raúl de la Fuente-Fernández, Michael Schulzer, Lisa Kuramoto, Jacquelyn Cragg, Nandhagopal Ramachandiran, Wing L Au, Edwin Mak, Jess McKenzie, Siobhan McCormick, Vesna Sossi,[...]. Ann Neurol 2011
150
15

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
13

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123 I]-FP-CIT SPECT imaging: The [123 I]-FP-CIT study group.
Hani T S Benamer, Jim Patterson, Donald G Grosset, J Booij, K de Bruin, E van Royen, J D Speelman, M H I M Horstink, H J W A Sips, R A Dierckx,[...]. Mov Disord 2000
236
12

Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.
Vesna Sossi, Raúl de la Fuente-Fernández, Michael Schulzer, Andre R Troiano, Thomas J Ruth, A Jon Stoessl. Ann Neurol 2007
93
12

Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.
Anna I Blazejewska, Stefan T Schwarz, Alain Pitiot, Mary C Stephenson, James Lowe, Nin Bajaj, Richard W Bowtell, Dorothee P Auer, Penny A Gowland. Neurology 2013
155
12

[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression.
K Marek, R Innis, C van Dyck, B Fussell, M Early, S Eberly, D Oakes, J Seibyl. Neurology 2001
243
12

Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.
Marios Politis, Kit Wu, Clare Loane, David J Brooks, Lorenzo Kiferle, Federico E Turkheimer, Peter Bain, Sophie Molloy, Paola Piccini. J Clin Invest 2014
149
11

Clinical progression in Parkinson disease and the neurobiology of axons.
Hsiao-Chun Cheng, Christina M Ulane, Robert E Burke. Ann Neurol 2010
423
11

Changes in network activity with the progression of Parkinson's disease.
Chaorui Huang, Chengke Tang, Andrew Feigin, Martin Lesser, Yilong Ma, Michael Pourfar, Vijay Dhawan, David Eidelberg. Brain 2007
271
11

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
Alan L Whone, Ray L Watts, A Jon Stoessl, Margaret Davis, Sven Reske, Claude Nahmias, Anthony E Lang, Olivier Rascol, Maria J Ribeiro, Philippe Remy,[...]. Ann Neurol 2003
588
11

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.
J P Seibyl, K L Marek, D Quinlan, K Sheff, S Zoghbi, Y Zea-Ponce, R M Baldwin, B Fussell, E O Smith, D S Charney,[...]. Ann Neurol 1995
384
10

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
H Bernheimer, W Birkmayer, O Hornykiewicz, K Jellinger, F Seitelberger. J Neurol Sci 1973
10


Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.
Julia Kraemmer, Gabor G Kovacs, Laura Perju-Dumbrava, Susanne Pirker, Tatiana Traub-Weidinger, Walter Pirker. Mov Disord 2014
70
14

Dopamine Transporter SPECT Imaging in Corticobasal Syndrome.
Roberto Cilia, Carlo Rossi, Daniela Frosini, Duccio Volterrani, Chiara Siri, Cristina Pagni, Riccardo Benti, Gianni Pezzoli, Ubaldo Bonuccelli, Angelo Antonini,[...]. PLoS One 2011
52
17

Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study.
Marios Politis, Kit Wu, Clare Loane, Lorenzo Kiferle, Sophie Molloy, David J Brooks, Paola Piccini. Neurobiol Dis 2010
153
9

FDG PET in the differential diagnosis of parkinsonian disorders.
Thomas Eckert, Anna Barnes, Vijay Dhawan, Steve Frucht, Mark F Gordon, Andrew S Feigin, D Eidelberg. Neuroimage 2005
225
9

MDS clinical diagnostic criteria for Parkinson's disease.
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
9


Idiopathic hyposmia as a preclinical sign of Parkinson's disease.
Mirthe M Ponsen, Diederick Stoffers, Jan Booij, Berthe L F van Eck-Smit, Erik Ch Wolters, Henk W Berendse. Ann Neurol 2004
472
8

Validation of nigrostriatal positron emission tomography measures: critical limits.
Morvarid Karimi, LinLin Tian, Christopher A Brown, Hubert P Flores, Susan K Loftin, Tom O Videen, Stephen M Moerlein, Joel S Perlmutter. Ann Neurol 2013
46
17

Levodopa and the progression of Parkinson's disease.
Stanley Fahn, David Oakes, Ira Shoulson, Karl Kieburtz, Alice Rudolph, Anthony Lang, C Warren Olanow, Caroline Tanner, Kenneth Marek. N Engl J Med 2004
8


Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
D J Brooks, V Ibanez, G V Sawle, N Quinn, A J Lees, C J Mathias, R Bannister, C D Marsden, R S Frackowiak. Ann Neurol 1990
499
8

Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data.
Vesna Sossi, Raúl de La Fuente-Fernández, James E Holden, Doris J Doudet, Jess McKenzie, A J Stoessl, T J Ruth. J Cereb Blood Flow Metab 2002
89
8

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
C Warren Olanow, Christopher G Goetz, Jeffrey H Kordower, A Jon Stoessl, Vesna Sossi, Mitchell F Brin, Kathleen M Shannon, G Michael Nauert, Daniel P Perl, James Godbold,[...]. Ann Neurol 2003
996
8

Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms.
Vesna Sossi, Raúl de la Fuente-Fernández, James E Holden, Michael Schulzer, Thomas J Ruth, Jon Stoessl. J Cereb Blood Flow Metab 2004
66
12

Microglial activation and dopamine terminal loss in early Parkinson's disease.
Yasuomi Ouchi, Etsuji Yoshikawa, Yoshimoto Sekine, Masami Futatsubashi, Toshihiko Kanno, Tomomi Ogusu, Tatsuo Torizuka. Ann Neurol 2005
522
8

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.
Alexander Gerhard, Nicola Pavese, Gary Hotton, Federico Turkheimer, Meltem Es, Alexander Hammers, Karla Eggert, Wolfgang Oertel, Richard B Banati, David J Brooks. Neurobiol Dis 2006
655
8

Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients.
M Plotkin, H Amthauer, S Klaffke, A Kühn, L Lüdemann, G Arnold, K-D Wernecke, A Kupsch, R Felix, S Venz. J Neural Transm (Vienna) 2005
142
8

Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.
Nicolaas I Bohnen, Roger L Albin, Robert A Koeppe, Kristine A Wernette, Michael R Kilbourn, Satoshi Minoshima, Kirk A Frey. J Cereb Blood Flow Metab 2006
170
8


Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
F J Vingerhoets, M Schulzer, D B Calne, B J Snow. Ann Neurol 1997
258
7

Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT.
Vicky L Marshall, Cornelia B Reininger, Moritz Marquardt, Jim Patterson, Donald M Hadley, Wolfgang H Oertel, Hani T S Benamer, Paul Kemp, David Burn, Eduardo Tolosa,[...]. Mov Disord 2009
126
7


In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133.
Nobuyuki Okamura, Victor L Villemagne, John Drago, Svetlana Pejoska, Rajinder K Dhamija, Rachel S Mulligan, Julia R Ellis, Uwe Ackermann, Graeme O'Keefe, Gareth Jones,[...]. J Nucl Med 2010
84
8

Epidemiology of Parkinson's disease.
Lonneke M L de Lau, Monique M B Breteler. Lancet Neurol 2006
7

Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls.
S A Eshuis, P L Jager, R P Maguire, S Jonkman, R A Dierckx, K L Leenders. Eur J Nucl Med Mol Imaging 2009
61
11

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.
Raúl de la Fuente-Fernández, Vesna Sossi, Zhigao Huang, Sarah Furtado, Jian-Qiang Lu, Donald B Calne, Thomas J Ruth, A Jon Stoessl. Brain 2004
289
7

Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.
R de la Fuente-Fernández, J Q Lu, V Sossi, S Jivan, M Schulzer, J E Holden, C S Lee, T J Ruth, D B Calne, A J Stoessl. Ann Neurol 2001
148
7

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels.
B J Snow, I Tooyama, E G McGeer, T Yamada, D B Calne, H Takahashi, H Kimura. Ann Neurol 1993
271
7

Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias.
Sean J Colloby, Shane McParland, John T O'Brien, Johannes Attems. Brain 2012
105
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.